-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Revelation Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2025.
- Revelation Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $873.000, a 97.3% decline year-over-year.
- Revelation Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $329K, a 156% increase year-over-year.
- Revelation Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $169K, a 8.43% increase from 2023.
- Revelation Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $156K, a 48.3% decline from 2022.
- Revelation Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $301K, a 36.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)